KCM Clinic
| Polonia | Turchia | Austria | |
| Trapianto di midollo osseo allogenico da donatore non correlato | da $100,000 | da $80,000 | da $180,000 |
| Trapianto di midollo osseo allogenico da donatore consanguineo | da $75,000 | da $65,000 | da $150,000 |
| Trapianto di midollo osseo | da $80,000 | da $36,000 | da $140,000 |
| Terapia con cellule CAR-T | da $150,000 | da $150,000 | da $350,000 |
| Terapia biologica | da $9,000 | da $5,500 | da $20,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Ematologia Oncologia. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Ematologia Oncologia e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento di procedure di Ematologia Oncologia.
Cancer treatment in Poland is not automatically free for international patients. Coverage depends on legal residency or mandatory contributions to the National Health Fund (NFZ). Non-residents typically pay out-of-pocket for oncology services at private facilities like European Health Center Otwock or the Institute of Cybernetic Surgery Cyberknife.
Bookimed Expert Insight: Poland's private oncology sector offers a strategic advantage for patients with heart conditions. European Health Center Otwock operates the only interdisciplinary cardio-oncology department in the country. This setup allows for intensive cancer treatment while active heart monitoring protects the patient's cardiovascular health during chemotherapy.
Patient Consensus: Patients note that private clinics in major cities provide treatment at significantly lower costs than Western Europe. It is vital to bring translated medical records and expect upfront cash payments unless you have pre-approved international insurance.
The Fast Oncology Therapy Card (DiLO) is a green patient document providing priority access to cancer care in Poland. It bypasses standard waiting lists to ensure rapid diagnosis and treatment. This fast-track system mandates specific timelines for cancer confirmation and the start of medical intervention.
Bookimed Expert Insight: Clinical data shows specialized centers like European Health Center Otwock often provide more integrated care for DiLO holders. This facility uniquely combines oncology and cardiology departments. This is vital for patients needing cancer treatment while managing heart conditions. Choosing such specialized hubs can reduce the risk of treatment delays caused by transferring between different hospitals.
Patient Consensus: Patients note that the DiLO card is essential for accessing expensive targeted therapies for leukemia or lymphoma without 6-month waits. They suggest applying immediately after a biopsy and seeking second opinions if an initial application is rejected for urgency.
International patients access innovative cancer drugs in Poland through clinical trials and private oncology centers. Facilities like European Health Center Otwock provide advanced therapies. Poland follows European Medicines Agency (EMA) approvals. Most breakthroughs are available via private payment or research enrollment.
Bookimed Expert Insight: Data shows a high concentration of research-led care near Warsaw. European Health Center Otwock is the only interdisciplinary cardio-oncology department in Poland. This specialization is vital for patients using intensive therapies that may affect heart health. Choosing such integrated centers reduces the need for external specialists during treatment.
Patient Consensus: Patients note that private clinics are the only realistic option for time-sensitive cases to avoid 2–4 month waits. Many emphasize starting the paperwork 6 weeks early to confirm drug importation permits before traveling.
Poland offers high-authority hematology-oncology care through specialized centers like European Health Center Otwock and the Institute of Cybernetic Surgery Cyberknife. These facilities provide advanced diagnostics and treatments. Services include bone marrow transplantation, biological therapy, and non-invasive robotic radiosurgery for complex blood cancers.
Bookimed Expert Insight: Data shows that European Health Center Otwock is a unique choice for patients with pre-existing heart conditions. This clinic integrates oncology with cardiology. Most centers focus only on cancer. Choosing a facility with a cardio-oncology department helps manage treatment risks for heart-sensitive patients. This dual specialization is rare in private Polish healthcare.
Patient Consensus: Patients note it's helpful to use private clinics for fast diagnostics before starting treatment in the public system. They also emphasize that having a navigator helps manage the process more smoothly.